Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - EPA:GBT - FR0000032526 - Common Stock

15.12 EUR
-4.22 (-21.82%)
Last: 9/16/2025, 5:29:59 PM
Fundamental Rating

5

GBT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of GBT get a neutral evaluation. Nothing too spectacular is happening here. GBT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

GBT had positive earnings in the past year.
In the past year GBT had a positive cash flow from operations.
GBT had positive earnings in 4 of the past 5 years.
In the past 5 years GBT always reported a positive cash flow from operatings.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

GBT has a Return On Assets of 1.55%. This is comparable to the rest of the industry: GBT outperforms 45.76% of its industry peers.
GBT has a Return On Equity (4.08%) which is in line with its industry peers.
GBT has a Return On Invested Capital (4.48%) which is comparable to the rest of the industry.
GBT had an Average Return On Invested Capital over the past 3 years of 4.08%. This is below the industry average of 8.90%.
The 3 year average ROIC (4.08%) for GBT is below the current ROIC(4.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.55%
ROE 4.08%
ROIC 4.48%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

GBT has a Profit Margin (1.91%) which is in line with its industry peers.
In the last couple of years the Profit Margin of GBT has declined.
Looking at the Operating Margin, with a value of 5.89%, GBT is in line with its industry, outperforming 42.37% of the companies in the same industry.
GBT's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 77.94%, GBT belongs to the best of the industry, outperforming 88.14% of the companies in the same industry.
GBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.89%
PM (TTM) 1.91%
GM 77.94%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GBT has an Altman-Z score of 2.16. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.16) which is comparable to the rest of the industry.
The Debt to FCF ratio of GBT is 16.18, which is on the high side as it means it would take GBT, 16.18 years of fcf income to pay off all of its debts.
GBT's Debt to FCF ratio of 16.18 is in line compared to the rest of the industry. GBT outperforms 49.15% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that GBT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.89, GBT is not doing good in the industry: 76.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 16.18
Altman-Z 2.16
ROIC/WACC0.68
WACC6.6%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.32 indicates that GBT has no problem at all paying its short term obligations.
GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 67.80% of its industry peers.
A Quick Ratio of 1.13 indicates that GBT should not have too much problems paying its short term obligations.
GBT's Quick ratio of 1.13 is in line compared to the rest of the industry. GBT outperforms 52.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.13
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The earnings per share for GBT have decreased strongly by -34.20% in the last year.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
The Revenue has been growing slightly by 7.05% in the past year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%

3.2 Future

Based on estimates for the next years, GBT will show a small growth in Earnings Per Share. The EPS will grow by 6.72% on average per year.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.59% on average per year.
EPS Next Y-25.91%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y3.21%
Revenue Next 3Y3.59%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.91, which indicates a very decent valuation of GBT.
GBT's Price/Earnings ratio is rather cheap when compared to the industry. GBT is cheaper than 93.22% of the companies in the same industry.
GBT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.27.
With a Price/Forward Earnings ratio of 7.93, the valuation of GBT can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 93.22% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, GBT is valued rather cheaply.
Industry RankSector Rank
PE 11.91
Fwd PE 7.93
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 91.53% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaply inside the industry as 93.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.89
EV/EBITDA 3.89
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.49%
EPS Next 3Y6.72%

4

5. Dividend

5.1 Amount

GBT has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
The stock price of GBT dropped by -30.80% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
GBT's Dividend Yield is rather good when compared to the industry average which is at 2.30. GBT pays more dividend than 84.75% of the companies in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

GBT pays out 39.20% of its income as dividend. This is a sustainable payout ratio.
DP39.2%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (9/16/2025, 5:29:59 PM)

15.12

-4.22 (-21.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-24 2025-04-24
Earnings (Next)09-24 2025-09-24
Inst Owners18.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap191.12M
Analysts75
Price Target26.78 (77.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP39.2%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.67%
PT rev (3m)-3.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.65%
EPS NY rev (3m)-24.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 11.91
Fwd PE 7.93
P/S 0.23
P/FCF 7.89
P/OCF 2.35
P/B 0.48
P/tB 0.66
EV/EBITDA 3.89
EPS(TTM)1.27
EY8.4%
EPS(NY)1.91
Fwd EY12.61%
FCF(TTM)1.92
FCFY12.68%
OCF(TTM)6.43
OCFY42.5%
SpS66.54
BVpS31.19
TBVpS22.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 4.08%
ROCE 6.33%
ROIC 4.48%
ROICexc 5.17%
ROICexgc 6.14%
OM 5.89%
PM (TTM) 1.91%
GM 77.94%
FCFM 2.88%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.82%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 16.18
Debt/EBITDA 2.86
Cap/Depr 77.91%
Cap/Sales 6.78%
Interest Coverage 2.42
Cash Conversion 66.19%
Profit Quality 150.63%
Current Ratio 2.32
Quick Ratio 1.13
Altman-Z 2.16
F-Score5
WACC6.6%
ROIC/WACC0.68
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.2%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-77.4%
EPS Next Y-25.91%
EPS Next 2Y-0.49%
EPS Next 3Y6.72%
EPS Next 5YN/A
Revenue 1Y (TTM)7.05%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%3.65%
Revenue Next Year2.48%
Revenue Next 2Y3.21%
Revenue Next 3Y3.59%
Revenue Next 5YN/A
EBIT growth 1Y28.18%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year108.81%
EBIT Next 3Y33.55%
EBIT Next 5YN/A
FCF growth 1Y182.76%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y196.03%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%